SCLERO.ORG is retiring 4-24-2021. Thank you for the memories! You'll still find us in the Wayback Machine, and we'll carry your stories in our hearts forever.
Scleroderma Newsroom
ISN News Manager: Jo Frowde
Media Stories
Autoimmune Archive
We maintain news archives for the most recent 3 years.
2018: Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
2021 - 2020 - 2019 - 2018

July 2018 Autoimmune News

Oxidative stress in autoimmune rheumatic diseases. The detection of autoantibodies against specific antigens, might improve both early diagnosis and monitoring of disease activity. PubMed, Free Radic Biol Med, 05/30/2018. (Also see Oxidative Stress)

The Fatigue Assessment Scale (FAS): quality and availability in sarcoidosis and other diseases. The FAS has good psychometric qualities for the diseases in which it has been examined, including sarcoidosis, and can be used in clinical practice. PubMed, Curr Opin Pulm Med, 06/07/2018. (Also see Fatigue and Sarcoidosis)

Ability of disease–modifying antirheumatic drugs to prevent or delay rheumatoid arthritis (RA) onset: a systematic literature review and meta–analysis (MA). This MA demonstrates that early therapeutic intervention may significantly reduce the risk of RA onset in this very first phase of the disease. PubMed, Ann Rheum Dis, 06/08/2018. (Also see Treatments for Rheumatoid Arthritis and DMARDs)

Elevated levels of plasma symmetric dimethylarginine and increased arginase activity as potential indicators of cardiovascular comorbidity in rheumatoid arthritis (RA). This dysregulated L-arginine metabolism may function as a potential indicator of cardiovascular disease risk in patients with RA. PubMed, Arthritis Res Ther, 2018 Jun 8;20(1):123. (Also see Symptoms and Complications of Rheumatoid Arthritis)

The pathogenesis of psoriatic arthritis. Improving our understanding of psoriatic arthritis pathogenesis could help to establish validated biomarkers for diagnosis. PubMed, Lancet, 2018 Jun 2;391(10136):2273-2284. (Also see Psoriasis and Psoriatic Arthritis)

The relationship of endocannabinoidome lipid mediators with pain and psychological stress in women with fibromyalgia (FM)– a case control study. This study reports about elevated plasma levels of endocannabinoidome lipid mediators in FM. PubMed, J Pain, 06/06/2018. (Also see Endocannabinoid System and Treatments for Fibromyalgia)

The relationship between body mass index and pain, disease activity, depression and anxiety in women with fibromyalgia (FMS). Obese female FMS patients had higher levels of pain, tender point count, disease activity and depression. PubMed, PeerJ, 2018 May 28;6:e4917. (Also see Fibromyalgia)

Rheumatic Disease Autoantibodies in Patients with Autoimmune Thyroid Diseases (ATD). We found rheumatic autoantibodies in 17.5% of ATD patients without rheumatic diseases and there was no clinical rheumatic disorder during the period of five years. PubMed, Med Princ Pract, 06/04/2018. (Also see Thyroid Diseases and Systemic Autoimmune Rheumatic Diseases)

Comparison of clinical characteristics of radiological forms of autoimmune pancreatitis (AIP). Diffuse–type and head–type AIP patients had similar clinical features. The body and/or tail–type group differed significantly from the other two types. PubMed, HPB (Oxford), 05/26/2018. (Also see Autoimmune Pancreatitis)

Hypothyroidism in patients with autoimmune pancreatitis. Further studies are necessary to clarify whether this subclinical hypothyroidism is another manifestation of IgG4-RD. PubMed, World J Gastrointest Pharmacol Ther, 2018 May 6;9(2):16-21. (Also see Autoimmune Pancreatitis and Thyroid Diseases)

Go to Autoimmune News: June 2018

SCLERO.ORG was the world's leading nonprofit for trustworthy research, support, education and awareness for scleroderma and related illnesses from 1998 to 2021. It was a grassroots movement from the original Scleroderma from A to Z web site, which was founded by Shelley Ensz. We were a 501(c)(3) U.S.-based public charitable foundation. We closed this web site and our nonprofit agency in April 2021.

International Scleroderma Network (ISN)